Spent half the week with my colleagues from Brazil discussing CAR T-cell in MM.... just in time to defend an opposing view vs. the great Sham Mailankody 😄

Join us next Saturday for a day of learning from top myeloma specialists in Charlotte! Link to register: buff.ly/49Vy8nN

Speaking at the Atlanta Myeloma Symposium today. Great to hear from colleagues including Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Luciano J Costa Craig Hofmeister

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk | Blood Cancer Journal #mmsm ⁦Alliance for Clinical Trials in Oncology⁩ ⁦Plasma Cell Pete⁩ ⁦Natalie Callander⁩ ⁦Memorial Sloan Kettering Cancer Center⁩ ⁦ nature.com/articles/s4140…

Save the date🔔 We're going to Charlotte on Mary 4th. Registration is OPEN! Find more info here: buff.ly/3W1ylCE Luciano J Costa Dr.MHB

Great news for those from the US, Canada and Australia joining us in RIO for the Myeloma Society meeting in September- Visas not required until April 2025!

apnews.com/article/brazil…

Getting MRD as an endpoint was a great partnership between academia and industry and patient organization. A model to follow. Patients are three winner. Vincent Rajkumar #@NoopurRajeMD #myelomasociety

Apresentamos hoje mais convidados internacionais confirmados no #SBTMO24 , que acontecerá de 31 de julho a 3 de agosto, no Centro de Eventos de Fortaleza (CE).

Preparem-se – e já garantam uma vaga. Esperamos por vocês – acessem congressosbtmo.org.br

#TMOJUntos

III multiregional SBTMO 🇧🇷 meeting about prevention and treatment of relapse after HCT! Our very good friend Luciano J Costa talked about New approaches in the treatment of Multiple Myeloma relapsed after autologous HSCT! 🔝🔝🔝

The Call for Abstracts for #IMS24 is now open! View the guidelines and start your submission here: events.jspargo.com/ims24/Public/C…

Awesome evening with a dear patient, clinical trial participant ⁦O'Neal Comprehensive Cancer Center at UAB⁩ and ultimate champion. Icing on the cake: The blazers won, and i got the spread the good word about clinical trials ⁦UAB⁩

Star-struck in Brazil! ⁦⁦marivi mateos⁩ ⁦Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽⁩

Luciano J Costa #haimatus24 👏🏻

português, português, portuñol: more things in common than how we spell mieloma

Attention #MYELOMA world, join Myeloma Society in Toronto 2025: mark your calendar and keep up to date with the science while experiencing one of the worlds most vibrant and multi-cultural cities Vincent Rajkumar Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Gareth Morgan nizar jacques bahlis Hira Mian Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰

A Hero x2

A joy to share the stage with these 2 gentlemen and hematology giants. Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽

🗣️ #ESHMM2024 words from Suzanne Lentzsch, MD, PhD
Join her and her co-chairs Hartmut Goldschmidt & Martin Kaiser on October 4-6, 2024 in Mandelieu-La Napoule🇫🇷
Register now for this conference ➡bit.ly/3WOpbaI
7th Translational Research Conference
MULTIPLE #MYELOMA
#ESHCONFERENCES #MMsm

Results of subsequent therapy for patients receiving QUADs/ASCT upfront #mmsm British Journal of Haematology | Wiley Online Library ⁦Susan Bal⁩ ⁦Smit Giri MD MHS⁩ onlinelibrary.wiley.com/doi/10.1111/bj…

Three medical oncologists explore the influence of MRD negativity rates on treatment decisions and discover the ideal patient profile for a quadruplet regimen. #mmsm | Luciano J Costa Larry Anderson,MD,PhD,FACP

cancernetwork.com/view/role-of-m…